SHM comments on the quality improvement section of the proposed Common Rule changes from the Office for Human Resarch Protections (OHRP)

SHM sends a letter to the Senate Health, Education, Labor and Pensions Committee in support of Scott Gottlieb, MD as Commissioner of FDA.

Along with other organizations, SHM signs on to a letter voicing concerns on provisions of the Program Integrity to the Provider Enrollment Process proposed rule.

SHM urges Congress to act now to restore funding for CHIP and ensure millions of children nationwide have access to health care. We stand ready to help move this important priority forward.

SHM provides comments on proposals for changes to inpatient admission orders documentation requirements and hospital-level performance measures.

Along with other organizations, SHM signed onto a letter to CMS addressing proposed changes to E&M documentation.

Along with other organizations, SHM signs onto support letter to House and Senate requesting AHRQ funding be maintained.

The Mainstreaming Addiction Treatment Act (H.R. 2482) will increase access to buprenorphine, a lifesaving addiction treatment, by eliminating the "X Waiver" DEA certificate and the

As the House Ways and Means Health Subcommittee considers legislation to curb surprise billing, the National Observation Stays Coalition, which includes medical associations and patient advocacy

The Reducing Administrative Costs and Burdens in Health Care Act of 2019 (S. 1260) encourages federal and state-level innovation to lower health care costs by reducing excessive administrative